View all research projects
Research project

Production of Technology Assessment Reviews (TARs) for the National Institute of Health Research (NIHR) 2016-2022

Staff

Lead researchers

Professor Andrew Cook MBBS MPH FFPH

Professorial Fellow in HTA
Research interests
  • Pragmatic Clinical Trials
  • Research Conduct
  • Guidelines
Connect with Andrew

Email: andrewc@soton.ac.uk

Other researchers

Professor Joanne Lord

Director of SHTAC
Research interests
  • Joanne has research interests in health economic evaluation and decision modelling.
  • She has worked on a wide range of applied cost-effectiveness studies, including:
  • a review of newborn screening for inborn errors of metabolism;trials of diagnosis, patient education, structured decision-making and therapeutic interventions for arthritis and back pain;evaluations of diagnostic tests, preventive treatment and contact tracing for tuberculosis;a model of geographic allocation of resources for control of Chagas disease in Central America; andanalyses relating to the prevention and treatment of cardiovascular diseases. Her methodological contributions include an MRC funded project on whole pathway modelling for NICE clinical guidelines and an economic perspective on test evaluation. She has also contributed to health outcome and quality of life studies.
Connect with Joanne

Email: J.Lord@soton.ac.uk

Collaborating research institutes, centres and groups

Research outputs

Cabozantinib for untreated locally advanced or metastatic renal cell carcinoma
Jonathan Shepherd, Joanne Lord, Petra Harris, Oluchukwu Onyimadu, Geoffrey Frampton & Maria Chorozoglou, 2018
Type: report
Daratumumab (with bortezomib and dexamethasone) for treating relapsed, refractory multiple myeloma
Neelam Kalita, Karen Pickett, Joanne Lord, Geoffrey Frampton, G. Lily Yao & Joanna Picot, 2018
Type: report
Etelcalcetide for treating secondary hyperparathyroidism
Karen Pickett, Joanne Lord, Micah J Rose, Jonathan Shepherd & Petra Harris, 2018
Type: report
Ocrelizumab for treating relapsing multiple sclerosis
Joanne Lord, Oluchukwu Onyimadu, Petra B Harris, Jonathan Shepherd & Geoffrey Frampton, 2018
Type: report
Abemaciclib with an aromatase inhibitor for untreated advanced hormone receptor-positive, HER2-negative breast cancer
Jonathan Shepherd, Oluchukwu Onyimadu, Jillian Colquitt, Petra B Harris, Emma Loveman & Joanne Lord, 2018
Type: report
Atezolizumab in combination for treating advanced non-squamous non-small-cell lung cancer: A Single Technology Appraisal
Oluchukwu Onyimadu, Joanne Lord, Joanna Picot, Keith Cooper, David A. Scott & Jonathan Shepherd, 2018
Type: report
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. A Single Technology Appraisal
Keith Cooper, Joanna Picot, Oluchukwu Onyimadu, Jonathan Shepherd, Joanne Lord & David A. Scott, 2018
Type: report